GL, M., EL, P., K, B., LA, V., JL, H., JA, D., . . . CS, B. (2023). gyrA Mutations in Mycoplasma genitalium and Their Contribution to Moxifloxacin Failure: Time for the Next Generation of Resistance-Guided Therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 76(12), 2187. https://doi.org/10.1093/cid/ciad057
Chicago Style (17th ed.) CitationGL, Murray, et al. "GyrA Mutations in Mycoplasma Genitalium and Their Contribution to Moxifloxacin Failure: Time for the Next Generation of Resistance-Guided Therapy." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 76, no. 12 (2023): 2187. https://doi.org/10.1093/cid/ciad057.
MLA (9th ed.) CitationGL, Murray, et al. "GyrA Mutations in Mycoplasma Genitalium and Their Contribution to Moxifloxacin Failure: Time for the Next Generation of Resistance-Guided Therapy." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 76, no. 12, 2023, p. 2187, https://doi.org/10.1093/cid/ciad057.
